NVO News and Press, Novo Nordisk A/S

2024-07-22 04:46:47 ET Summary I discuss my "Top 20 Stocks" list, focusing on high-quality companies with strong fundamentals and growth prospects. The list includes companies like S&P Global, Visa, Apple, and Waste Management, with brief explanations for each selection. I...

2024-07-21 21:02:13 ET More on health care stocks Elevance Health: Buy A Dividend Growth Machine Elevance extends losses as BofA cuts on Medicaid headwinds What Eli Lilly Is Getting With The Acquisition Of Morphic Holding Merck: Among The Best Health Ca...

2024-07-21 07:00:00 ET More on AstraZeneca, Bristol-Myers, etc. Bristol-Myers Squibb - Investors Are Too Long-Term Focused Bristol-Myers Squibb Is A Bargain Now AstraZeneca Stock: Upgrading From 'Hold' To 'Buy' Ahead Of Q2 2024 Earnings Dividend Roundup: Gold...

2024-07-20 09:20:25 ET Summary VKTX's obesity therapy candidate, VK2735, demonstrates accelerated weight loss results compared to Wegovy/ Mounjaro and the next-gen candidates, including CagriSema/ Zepbound/ Retatrutide. This explains why the stock is trading at a notable premium c...

2024-07-19 10:59:42 ET Summary By 2030, the weight loss drug market is estimated to reach a significant size, attracting many competitors due to the high prevalence of obesity-related comorbidities. The Tema Obesity & Cardiometabolic ETF offers exposure to leading biotech and ...

2024-07-19 10:20:00 ET Summary In this inflationary environment, we have consistently made adjustments to focus on assets that we consider are capable of maintaining pricing power or are more attractively valued. In the second quarter of 2024, the Baird Chautauqua International Gr...

2024-07-19 07:21:36 ET More on Eli Lilly What Eli Lilly Is Getting With The Acquisition Of Morphic Holding Wall Street Lunch: Merger Monday In All Its Glory Eli Lilly Targets IBD, Takes Calculated Gamble With $3.2bn Morphic Deal Eli Lilly, Novo extend multi-d...

2024-07-18 13:15:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. International equities...

2024-07-18 13:05:34 ET More on Eli Lilly, Novo, etc. What Eli Lilly Is Getting With The Acquisition Of Morphic Holding Wall Street Lunch: Merger Monday In All Its Glory Eli Lilly Targets IBD, Takes Calculated Gamble With $3.2bn Morphic Deal Eli Lilly, Novo sl...

2024-07-17 14:09:20 ET More on AbbVie, Bristol-Myers, etc. Is Bristol-Myers Squibb's Rich Dividend Yield Worth The Patent Cliff Correction Risk? Johnson & Johnson (JNJ) Q2 2024 Earnings Call Transcript Don't Let The Market Fool You: Bristol-Myers Is Not A Value T...